Chimeric Antibodies Against Hepatitis B e-Antigen
Locally Delivered Alkaline Phosphatase for Treatment of Periodontal Disease
Treatment of Periodontal Disease via ENPPI Inhibition
This technology focuses on enhancing cementum production, a key component in treating periodontal regression. The method involves inhibiting ectonucleotide pyrophosphatase phosphodiesterases (ENPP1), enzymes that play a significant role in mineralization processes. Pyrophosphate (PPi) is known to impede the growth of hydroxyapatite crystals, essential for mineralization. ENPP1 catalyzes the hydrolysis of ATP, generating PPi, which then hinders mineralization.
DLX3 Knockout Mice for the Study Mouse Models of Tooth, Hair, and Epidermal Defects
This technology includes K14creDLX3 conditional knockout (cKO) mice which will be used to study ectodermal dysplasia disorders such as Amelogenesis Imperfecta, and to study molecular mechanisms of DLX3 regulation in skin and ectodermal appendages. DLX3 is expressed in the epidermis, hair matrix cells in the hair follicle and in the mesenchymal and epithelial compartment of the tooth during embryonic development. To determine the transcriptional network dependent on DLX3-function, we will generate and analyze an epithelial-specific conditional knockout of DLX3.
SARS-CoV-2 Neutralizing Nanobodies
Filed on 2021-02-19
Compounds, Compositions, and Methods for Treating And/Or Preventing Periodontal Disease
Filed on 2017-11-27
Antibodies to Hepatitis B E-Antigen And Diagnostic and Therapeutic Uses Thereof
Filed on 2017-07-19
Regulatory Genetic Variants of IL1RN
Filed on 2017-08-24
ENGINEERING NEURAL STEM CELLS USING HOMOLOGOUD RECOMBINATION
Filed on 2013-11-15